Details of Host Protein
| Host Protein General Information (ID: PT0902) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein Name | GAP SH3 domain-binding protein 2 (G3BP2) 
             | Gene Name | G3BP2 
             | ||||||
| Host Species | Homo sapiens 
             | Uniprot Entry Name | G3BP2_HUMAN 
             | ||||||
| Subcellular Location | Cytoplasm; Stress granule 
             | ||||||||
| External Link | |||||||||
| NCBI Gene ID | |||||||||
| Uniprot ID | |||||||||
| Ensembl ID | |||||||||
| HGNC ID | |||||||||
| Function in Host | 
              Scaffold protein that plays an essential role in cytoplasmicstress granule formation which acts as a platform for antiviralsignaling.
                            
                            [1]
              
                               Click to Show/Hide | ||||||||
| 3D Structure |  | ||||||||
| Function of This Protein During Virus Infection | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Virus Name | SARS-COV-2 | Protein Function | Anti-viral | [2] | |||||
| Infected Tissue | Lung | Infection Time | 24 h | ||||||
| Infected Cell | A549 Cells (Adenocarcinomic Human alveolar basal epithelial cells) | Cellosaurus ID | CVCL_H249 | ||||||
| Method Description | To detect the role of host protein G3BP2 in viral infection, G3BP2 protein knockout A549 Cells were infected with SARS-COV-2 for 24 h , and the effects on infection was detected through qRT-PCR. | ||||||||
| Results | It is reported that Knockdown of G3BP2 increases the percent of infected cells 150% compared with control group. | ||||||||
| Host Protein - Virus RNA Network | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Full List of Virus RNA Interacting with This Protien | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNA Region: 5'-UTR (hCoV-19/Wuhan-Hu-1/2019 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [3] | |||||||
| Strains Name | hCoV-19/Wuhan-Hu-1/2019 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | 5'-UTR 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Infection Cells | HEK293 Cells (Human embryonic kidney cell) (CVCL_0045 ) | ||||||||
| Cell Originated Tissue | Liver | ||||||||
| Infection Time | 48 h | ||||||||
| Interaction Score | Prot score = 98 | ||||||||
| Method Description | RNA-protein interaction detection (RaPID) assay; liquid chromatography with tandem mass spectrometry (LC-MS/MS) | ||||||||
| RNA Region: 5'-UTR (hCoV-19/South Korea/KCDC03/2020 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [4] | |||||||
| Strains Name | hCoV-19/South Korea/KCDC03/2020 
                 | ||||||||
| Strains Family | Alpha (B.1.1.7) 
                 | ||||||||
| RNA Binding Region | 5'-UTR 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Interaction Type | Directly bind to SARS-CoV-23 RNA's 5' UTR region | ||||||||
| Infection Cells | Vero cells (epithelial kidney cell) Vero cells (epithelial kidney cell) (CVCL_0059 ) | ||||||||
| Cell Originated Tissue | kidney | ||||||||
| Infection Time | 24 h | ||||||||
| Interaction Score | P-adjust < 0.05 | ||||||||
| Method Description | Modified RNA antisense purification coupled with mass spectrometry (RAP-MS); label-free quantification (LFQ); liquid chromatography with tandem mass spectrometry (LC-MS/MS) | ||||||||
| RNA Region: ORF1ab (hCoV-19/Wuhan-Hu-1/2019 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [5] | |||||||
| Strains Name | hCoV-19/Wuhan-Hu-1/2019 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | ORF1ab 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Interaction Type | Potential binding protein | ||||||||
| Method Description | ATtRACT Database; Position Weight Matrices (PWMs); TFBSTools R package | ||||||||
| RNA Region: ORF7a (hCoV-19/Wuhan-Hu-1/2019 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [5] | |||||||
| Strains Name | hCoV-19/Wuhan-Hu-1/2019 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | ORF7a 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Interaction Type | Potential binding protein | ||||||||
| Method Description | ATtRACT Database; Position Weight Matrices (PWMs); TFBSTools R package | ||||||||
| RNA Region: E region (hCoV-19/Wuhan-Hu-1/2019 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [5] | |||||||
| Strains Name | hCoV-19/Wuhan-Hu-1/2019 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | E region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Interaction Type | Potential binding protein | ||||||||
| Method Description | ATtRACT Database; Position Weight Matrices (PWMs); TFBSTools R package | ||||||||
| RNA Region: M region (hCoV-19/Wuhan-Hu-1/2019 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [5] | |||||||
| Strains Name | hCoV-19/Wuhan-Hu-1/2019 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | M region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Interaction Type | Potential binding protein | ||||||||
| Method Description | ATtRACT Database; Position Weight Matrices (PWMs); TFBSTools R package | ||||||||
| RNA Region: S region (hCoV-19/Wuhan-Hu-1/2019 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [5] | |||||||
| Strains Name | hCoV-19/Wuhan-Hu-1/2019 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | S region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Interaction Type | Potential binding protein | ||||||||
| Method Description | ATtRACT Database; Position Weight Matrices (PWMs); TFBSTools R package | ||||||||
| RNA Region: Not Specified Virus Region (hCov-OC43/VR-759 Quebec/2019 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [4] | |||||||
| Strains Name | hCov-OC43/VR-759 Quebec/2019 
                 | ||||||||
| Strains Family | Beta 
                 | ||||||||
| RNA Binding Region | Not Specified Virus Region 
                 | ||||||||
| Virus Name | Human coronavirus OC43 (HCov-OC43) 
                 | ||||||||
| Infection Cells | HCT-8 cells (Human ileocaecal adenocarcinoma cell) HCT-8 cells (Human ileocaecal adenocarcinoma cell) (CVCL_2478 ) | ||||||||
| Cell Originated Tissue | Ileocecum | ||||||||
| Infection Time | 12h; 24; 36h; 48h | ||||||||
| Interaction Score | p_value < 0.05; FDR < 10% | ||||||||
| Method Description | Modified RNA antisense purification coupled with mass spectrometry (RAP-MS); label-free quantification (LFQ); liquid chromatography with tandem mass spectrometry (LC-MS/MS) | ||||||||
| RNA Region: Not Specified Virus Region (hCoV-19/USA/WA1/2020 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [6] | |||||||
| Strains Name | hCoV-19/USA/WA1/2020 
                 | ||||||||
| Strains Family | Alpha (B.1.1.7) 
                 | ||||||||
| RNA Binding Region | Not Specified Virus Region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Infection Cells | Huh7.5 cells (Hepatocyte derived cellular carcinoma cell) Huh7.5 cells (Hepatocyte derived cellular carcinoma cell) (CVCL_7927 ) | ||||||||
| Cell Originated Tissue | Liver | ||||||||
| Infection Time | 48 h | ||||||||
| Interaction Score | FDR ≤ 0.05 | ||||||||
| Method Description | comprehensive identification of RNA-binding proteins by massspectrometry (ChIRP-MS) | ||||||||
| RNA Region: Not Specified Virus Region (hCoV-19/Not Specified Virus Strain ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [7] | |||||||
| Strains Name | hCoV-19/Not Specified Virus Strain 
                 | ||||||||
| RNA Binding Region | Not Specified Virus Region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Infection Cells | Huh7 cells (liver carcinoma cell) Huh7 cells (liver carcinoma cell) (CVCL_0336 ) | ||||||||
| Cell Originated Tissue | Liver | ||||||||
| Infection Time | 24h | ||||||||
| Interaction Score | log2FC = 9.32286E+14 | ||||||||
| Method Description | RNA antisense purification and quantitative mass spectrometry (RAP-MS); Tandem mass tag (TMT) labelling; liquid chromatography tandem mass spectrometry (LC-MS/MS); Westernblot | ||||||||
| RNA Region: Not Specified Virus Region (hCoV-19/France/IDF-220-95/2020 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [2] | |||||||
| Strains Name | hCoV-19/France/IDF-220-95/2020 
                 | ||||||||
| RNA Binding Region | Not Specified Virus Region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Interaction Type | Direct interaction | ||||||||
| Infection Cells | HEK293 Cells (Human embryonic kidney cell) HEK293 Cells (Human embryonic kidney cell) (CVCL_0045 ) | ||||||||
| Cell Originated Tissue | Kidney | ||||||||
| Infection Time | 48 h | ||||||||
| Interaction Score | SAINT score ≥ 0.79 | ||||||||
| Method Description | comprehensive identification of RNA-binding proteins by massspectrometry (ChIRP-MS) | ||||||||
| RNA Region: Not Specified Virus Region (hCoV-19/England/02/2020 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [8] | |||||||
| Strains Name | hCoV-19/England/02/2020 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | Not Specified Virus Region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Infection Cells | Calu-3 cells (Human lung cancer cell) Calu-3 cells (Human lung cancer cell) (CVCL_0609 ) | ||||||||
| Cell Originated Tissue | Lung | ||||||||
| Infection Time | 24 h | ||||||||
| Interaction Score | P-adjust = 0.005 | ||||||||
| Method Description | UV protein-RNA crosslinking; RNA interactome capture (cRIC); RNA antisense purification coupled with mass spectrometry (RAP-MS) | ||||||||
| RNA Region: Not Specified Virus Region (hCoV-19/England/02/2020 ) | |||||||||
| RNA Region Details | RNA Info  Click to show the detail information of this RNA binding region | [8] | |||||||
| Strains Name | hCoV-19/England/02/2020 
                 | ||||||||
| Strains Family | Beta (B.1.351) 
                 | ||||||||
| RNA Binding Region | Not Specified Virus Region 
                 | ||||||||
| Virus Name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
                 | ||||||||
| Infection Cells | Calu-3 cells (Human lung cancer cell) Calu-3 cells (Human lung cancer cell) (CVCL_0609 ) | ||||||||
| Cell Originated Tissue | Lung | ||||||||
| Infection Time | 24 h | ||||||||
| Interaction Score | P-adjust = 0.006 | ||||||||
| Method Description | UV protein-RNA crosslinking; RNA interactome capture (cRIC); RNA antisense purification coupled with mass spectrometry (RAP-MS) | ||||||||
| Differential Gene Expression During SARS-COV-2 Infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
 
 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Protein Phosphorylation after Virus Infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S163
                            [9] |  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S225
                            [9] |  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| T227
                            [10] |  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| T227
                            [9] |  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Y176
                            [9] |  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Protein Sequence Information | MVMEKPSPLLVGREFVRQYYTLLNKAPEYLHRFYGRNSSYVHGGVDASGKPQEAVYGQNDIHHKVLSLNFSECHTKIRHVDAHATLSDGVVVQVMGLLSNSGQPERKFMQTFVLAPEGSVPNKFYVHNDMFRYEDEVFGDSEPELDEESEDEVEEEQEERQPSPEPVQENANSGYYEAHPVTNGIEEPLEESSHEPEPEPESETKTEELKPQVEEKNLEELEEKSTTPPPAEPVSLPQEPPKAFSWASVTSKNLPPSGTVSSSGIPPHVKAPVSQPRVEAKPEVQSQPPRVREQRPRERPGFPPRGPRPGRGDMEQNDSDNRRIIRYPDSHQLFVGNLPHDIDENELKEFFMSFGNVVELRINTKGVGGKLPNFGFVVFDDSEPVQRILIAKPIMFRGEVRLNVEEKKTRAARERETRGGGDDRRDIRRNDRGPGGPRGIVGGGMMRDRDGRGPPPRGGMAQKLGSGRGTGQMEGRFTGQRR     Click to Show/Hide | 
|---|

 Home
 Home Search
 Search 
 Browse
 Browse  Download
 Download Manual
 Manual

